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Abstract: According to the World Health Organization (WHO), tobacco-related disease is 
the single largest preventable cause of death in the world today, killing around 5.4 million 
people a year – an average of one person every six seconds. The total number of death 
caused by tobacco consumption is higher than that of tuberculosis, HIV/AIDS and malaria 
combined. Unlike other communicable diseases, however, tobacco-related disease has a 
man-made consensus vector – the tobacco companies that play an active role to promote 
tobacco consumption, which directly heightens the disease morbidity. Any public health 
policy designed to curb smoking behavior has to prepare for opposite lobbying actions from 
tobacco companies that undermine the effects of the health measures. Another unique nature 
of the tobacco epidemic is that it can be cured, not by medicines or vaccines, but on the 
concerted actions of government and civil society. Many countries with a history of tobacco 
control measures indeed experienced a reduction of tobacco consumption. As most of these 
governments launched a range of measures simultaneously, it is hard to quantify the relative 
merits of different control strategies that contributed to the drop in the number of smokers. 
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These packages of strategies can come in different forms but with some common features. 
Political actions with government support, funding, and protection are crucial. Without 
these, antismoking efforts in any part of the world are unlikely to be successful. 
Keywords: Tobacco; smoking; cigarette; World Health Organization; epidemic. 
 
1. World Trend of Tobacco-related Diseases 
According to the World Health Organization (WHO), tobacco-related disease is the single largest 
preventable cause of death in the world today. Worldwide, tobacco–related disease accounts for more 
than five million deaths annually, more than tuberculosis, HIV/AIDS and malaria combined [1]. 
Although tobacco-related deaths rarely make headlines, tobacco consumption results in the premature 
death of a third to a half of all people who use it [2], on average 15 years prematurely [3, 4]. By 2030, 
the death toll will likely exceed eight millions a year. Unless urgent action is taken tobacco could kill 
one billion people in this century. 
There are already numerous publicity campaign and mass education programs on the harmful 
effects of smoking in many countries all over the world [5, 6]. Although most tobacco users want to 
quit, yet they are unable to do so because of their dependence on a highly addictive substance. 
Cigarettes and other tobacco products rapidly deliver the addictive drug nicotine to the brain 
immediately following inhalation – with an onset time comparable to an intravenously injection [7, 8]. 
The tobacco industry has referred cigarettes as a “nicotine delivery device” [9].  
Until recently, this epidemic of chronic disease and premature death mainly affected rich countries. 
The trend however is changing – by 2030, more than 80% of tobacco deaths will be in low-income and 
middle-income countries [10]. In rich countries, smoking is increasingly prevalent among the poor, 
and is responsible for much of their ill health and premature mortality [11]. 
In developing countries there has been an upsurge in the number of young men smoking. People in 
China, for example,
 smoke about 30% of the world's cigarettes. This will have
 catastrophic effects in 
the 21
st century as most other causes of death
 are likely to continue to decrease and the effects of 
tobacco
 to increase. If current smoking patterns persist – that is,
 if the smoking uptake rate among 
young adults continues to be
 substantial and the rate of stopping smoking at older ages continues
 to be 
low, by the time the children of today reach middle age
 smoking will be one of the main causes of 
premature death
 in the world [12]. In India, about a quarter of deaths among middle-aged men are 
caused by smoking. Today, India is the third largest country in the world in both tobacco production 
and consumption. Of the 1.1 billion smokers worldwide, 182 million live in India [13]. As the number 
of smokers in the developing world increases with population growth, so will the number of tobacco-
related deaths. The shift of the tobacco epidemic to the developing world will lead to unprecedented 
levels of disease and early death in countries where population growth and the potential for increased 
tobacco use are highest and where health-care services are least available. Most of the health damages 
caused by tobacco consumption do not become evident until years or even decades after its use. So, 
while tobacco use is rising globally, the epidemic of tobacco-related disease and death has just begun. Int. J. Environ. Res. Public Health 2009, 6          
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1.1. The Vector - Tobacco Companies 
All epidemics have a means of contagion, a vector that spreads disease, and death. For the tobacco 
epidemic, the vector is not a virus, bacterium or other microorganism – it is an industry and its 
business strategy. The epidemic of tobacco use and diseases would not exist without the tobacco 
industry’s marketing and promotion of its deadly products over the past century.  
Under the terms of the 1998 Minnesota Consent Judgment and the Master Settlement Agreement 
(MSA), six leading international tobacco companies were ordered to make millions of pages of their 
internal documents available to the public as the result of legal action taken by the United States of 
America. The MSA was originally signed by the four largest tobacco companies, Philip Morris USA, 
R. J. Reynolds Tobacco Company, Brown & Williamson Tobacco Corp., and Lorillard Tobacco 
Company and was later joined by over 40 other tobacco companies. 46 U.S. states and 6 U.S. 
territories signed the agreement. The other U.S. states Florida, Minnesota, Texas and Mississippi had 
already reached individual agreements with the tobacco industry. With the exception of British 
American Tobacco and the Liggett Group, the companies were also required to post their documents 
on public websites and to maintain these sites until June 30, 2010. The estimated 40 million pages in 
the collections have disclosed, amongst many other insights that the industry has known about health 
risks associated with tobacco use for years and has contrived to keep this information from the public 
[14]. These documents indicated that tobacco companies have long targeted youth as “replacement 
smokers” to take the place of those who quit or die [15-18]. The industry knows that addicting youth is 
hope for its future. Although anyone who uses tobacco can become addicted to nicotine, people who 
do not start smoking before age 21 are unlikely to ever begin. The younger the children or adolescents 
are when they first try smoking, the more likely they are to become regular smokers and the less likely 
they are to quit [19, 20].  
Because of an addicted customer base and high profit margins, tobacco companies have very strong 
financial positions, and with these, political strengths. Worldwide, the tobacco industry spends tens of 
billions of dollars a year on marketing. In recent years, global tobacco giants have bought majority 
stakes in tobacco companies in the Dominican Republics, Indonesia, Mexico and Pakistan, among 
other countries, to boost sales and use in the developing world [1]. There are also examples of 
concerted efforts of tobacco giants, mostly from the United Sates, to couple with the influence of their 
governments to exploit the tobacco markets of other countries. Korea, Taiwan, and Japan have all 
suffered threats of trade sanctions [21-23].  
Governments in developing countries may be under great pressure from the tobacco industry and its 
political allies, but they have obligation to safeguard the health of their own people. Government 
leaders hold the cure for the tobacco epidemic. There are many examples of successful actions that can 
reduce the health hazards of tobacco and each of them outlined below requires the support of the 
governments.  
 Int. J. Environ. Res. Public Health 2009, 6          
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2. Tobacco Control Policies 
On August 9, 2000, the U.S. Surgeon General released a report on tobacco, “Reducing Tobacco 
Use,” which found that smoking rates among teens and adults could be halved within a decade if the 
nation would fully implement anti-smoking programs using effective approaches that are already 
available [24]. Reports from the Institute of Medicine [25] and the Centers for Diseases Control and 
Prevention [26] suggested that comprehensive state tobacco control programs are effective public 
health investments. The claims are further supported by a recent research in which researchers were 
able to quantify the link between comprehensive tobacco control programs and a decrease in adult 
smoking – observing a decline in prevalence from 29.5 percent in 1985 to 18.6 percent in 2003 [27]. 
The study, “The Impact of Tobacco Control Programs on Adult Smoking”, published in 2008, is the 
first of its kind to use multi-state survey data on smoking to examine the association between 
cumulative state tobacco control program spending and changes in adult smoking prevalence [27]. 
Combining educational, clinical, regulatory, economic, and social strategies, these comprehensive 
programs encompass coordinated efforts to establish smoke-free policies and social norms, to promote 
and assist tobacco users to quit, and to prevent initiation of tobacco use.  
The U.K. Government is also reporting similar success in the range of policies it has successfully 
implemented to drive down smoking prevalence since the publication of the seminal white paper, 
Smoking Kills, in 1998 [28]. Indeed it has been reported that smoking rates in England have fallen 
from 28 per cent in 1998 to 22 per cent in 2006 with a reduction in smoking amongst routine and 
manual workers from 33 to 28 percentage points, with a similar picture across the U.K. [29]. 
In general, most of the countries around the world strongly favor policies that might prevent 
tobacco use among young people. These policies might include mandated tobacco education in schools, 
a complete ban on smoking on school grounds, further restrictions on tobacco advertising and 
promotional activities, stronger prohibitions on the sale of tobacco products to minors, and increases in 
earmarked taxes on tobacco products. Interventions to prevent initiation among young people, as well 
as actions that involve restrictions on adult smoking or increased taxes, have received strong support 
among smoking and nonsmoking adults. 
One key element in determining the relative merits of the various control strategies is the 
availability of data. Comprehensive data are important for convincing the leaders of governments, the 
general public and other stakeholders how the tobacco consumption harms the countries and what 
policy should be implemented and concentrated in order to protect their citizens. The data can also 
enable policy makers to gain “ownership” of the chosen interventions by providing them with the 
research findings on which the interventions are based. There might be other control policies that work 
on a local scale but the good experience cannot be shared without systematic data analysis and 
monitoring. The following discussion of effective tobacco control policies is based on well-
documented evidence.  
2.1. The Framework Convention on Tobacco Control (FCTC) 
On May 21, 2003, the World Health Assembly (WHA), the governing body of the WHO, 
unanimously adopted resolution WHA 56.1, which included adoption of the WHO Framework 
Convention on Tobacco Control (FCTC) [30]. The WHO FCTC consists of a series of negotiated Int. J. Environ. Res. Public Health 2009, 6          
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protocols within a general framework. The first three protocols are negotiations covering smuggling, 
advertising, and treatment of tobacco addiction. Countries agreeing to the negotiated protocols are to 
adopt appropriate legislation and, if necessary, implement the appropriate measures. 
The WHO FCTC opened for signature from 16 June to 22 June 2003 in Geneva, and thereafter at 
the United Nations Headquarters in New York, the Depositary of the treaty, from 30 June 2003 to 29 
June 2004. The treaty, which is now closed for signature, has 168 signatories, including the European 
Community, which makes it the most widely embraced treaty in the UN history. Member states that 
have signed the Convention indicate that they will strive in good faith to ratify, accept, or approve it, 
and show political commitment not to undermine the objectives set out in it. Countries wishing to 
become a Party, but that did not sign the Convention by 29 June 2004, may do so by means of 
accession, which is a one-step process equivalent to ratification.  
The WHO FCTC is the first treaty negotiated under the auspices of the WHO. It is an evidence-
based treaty that represents a paradigm shift in developing a regulatory strategy to address addictive 
substances; in contrast to previous drug control treaties, the WHO FCTC asserts the importance of 
demand reduction strategies as well as supply issues.  
On the demand reduction strategies, the WHO FCTC includes price and tax measures to reduce the 
demand for tobacco, and non-price measures to reduce the demand for tobacco, namely: protection 
from exposure to tobacco smoke; regulation of the contents of tobacco products; regulation of tobacco 
product disclosures; packaging and labeling of tobacco products; education, communication, training 
and public awareness; tobacco advertising, promotion and sponsorship; and, demand reduction 
measures concerning tobacco dependence and cessation. On the supply issue, the treaty addresses: 
illicit trade in tobacco products; sales to and by minors; and, provision of support for economically 
viable alternative activities [31]. 
Between 1999 and 2001, British American Tobacco, Philip Morris,
 and Japan Tobacco International 
executed Project Cerberus to
 develop a global voluntary regulatory regime as an alternative
 to the 
FCTC. They
 aimed to develop a global voluntary regulatory code to be overseen
 by an independent 
audit body and to focus attention on youth
 smoking prevention. Although the companies did not stop
 
the FCTC, they continue to promote the International Tobacco
 Products Marketing Standards youth 
smoking prevention as an
 alternative to the FCTC [32]. Fortunately many public health civil society 
groups helped policymakers and governments to understand the situation and many countries signed 
on the FCTC disregarding the alternative promoted by the tobacco companies. 
The major impact of the FCTC is to define international rules for tobacco control. Many countries 
then aim to follow the Convention to guarantee the adoption of some, if not all, measures that, based 
on the opinions of WHO, will effectively reduce tobacco consumption. There are some important 
measures that tended to be adopted more by many member states, probably due to their apparent 
effectiveness and their approaches are more acceptable and applicable to different countries. These 
approaches are outlined as follows. Int. J. Environ. Res. Public Health 2009, 6          
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2.2. Smoke-Free Policies 
Smoke-free policies, one of the most important measures to protect people from tobacco smoker, 
refer to restriction of smoking in public places. Smoke-free policies include legislative and other 
measures to protect against harmful exposure to second-hand smoke and are an integral part of the 
WHO FCTC. There are various degrees of restrictions and the only country to have banned the sale 
and smoking of tobacco in all public places is Bhutan, in early 2004. 
Environmental tobacco smoke or “second-hand smoke” is the complex mixture of chemicals 
generated during the burning of tobacco products. The primary rationale of government smoke-free 
laws is to protect people from the alleged harmful effects of second-hand smoke, which include an 
increased risk of heart disease, cancer, emphysema, and other diseases [33, 34]. Laws implementing 
bans on indoor smoking have been introduced by many countries in various forms over the years, with 
some legislators citing scientific evidence that shows tobacco smoking is harmful to the smokers 
themselves and to those inhaling second-hand smoke. 
Other than the immediate health benefits such as reduction of respiratory symptoms in workers in 
smoke-free workplace, the long-term health benefits of smoke-free laws on fatal diseases such as 
cancer and heart attacks are less easy to demonstrate. Conclusive research on such areas need 
enormous time and resources investment, not to mention the technical difficulties involved.  
There is an overwhelming scientific consensus that exposure to second-hand smoke cause disease, 
disability and death. Second-hand smoke contains over 4,000 chemicals and 69 known carcinogens 
including formaldehyde, cyanide, arsenic, carbon monoxide, methane, benzene, and radioactive 
polonium 210. Recent report from the US Surgeon General collated and collected vast amount of 
information over the years among various countries and finally concluded that second-hand smoke 
exposure increases the risk of coronary heart disease by 25-30% and the risk of lung cancer in non-
smokers by 20-30% [33]. Since second-hand smoke contributes to all these health problems, the 
implementation of smoke-free laws would result in a reduction in the risk of cancer, respiratory 
disease, heart disease and stroke [35]. 
From a public health standpoint, the greatest impact of smoke-free laws is to curb the smoking habit. 
The WHO considers smoke-free laws to have an influence to reduce demand for tobacco by creating 
an environment where smoking becomes increasing more difficult and to help shift social norms away 
from the acceptance of smoking in everyday life. Smoke-free environments also help smokers who 
want to quit. Smoke-free laws in workplaces were found to cut absolute smoking prevalence by 4% 
[36]. Smoke-free policies in workplaces in several industrialized nations have reduced total tobacco 
consumption among workers by an average of 29% [36]. Along with tax measures, cessation measures, 
and education, smoking ban policy is currently viewed as an important element in lowering smoking 
rates and promoting public health [1].  
It is generally agreed that comprehensive smoke-free regulations can reduce cigarette consumption, 
but that such policies work best when there is a strong social consensus against smoking in public 
places and therefore self-enforcement of the restrictions. Int. J. Environ. Res. Public Health 2009, 6          
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2.3. Health Publicity 
There are many studies on the effects of health publicity programs in curbing tobacco consumption 
and these effects are dependent on the medium used and the recipients’ social background.  For 
example, studies of rates of stopping smoking between
 1950 and 1980 in the United States suggest that 
health scares
 in the 1950s, which were largely carried by the print media,
 had relatively little influence 
on the prevalence of smoking
 in more deprived groups relative to the population as a whole.
 These 
groups were much more responsive, however, to later publicity
 in the electronic media –especially the 
"fairness doctrine"
 antismoking campaign on television between 1967 and 1970 [37]. Townsend and 
colleagues' study found that health publicity had relatively less influence on the smoking habits of 
more
 disadvantaged socioeconomic groups, and is therefore a source adding inequality [38].
 Smokers
 
in all social classes however responded equally to Sydney's "quit for
 life" campaign on television in 
1983 [39]. It appears that television, which is commonly watched by members across different social
 
classes, is a potentially class free medium
 for health promotion in comparison with the print media, 
though
 the latter probably have a correspondingly greater influence on decision
 makers [40]. 
Reviews of the impact of specific types of information (such as “information shocks” – the 
publication of new evidence on the health consequences of smoking – and warnings on cigarette packs) 
indicate that these can effectively reduce the prevalence of smoking in a population [41].  
The evidence suggests that government policies to increase consumer information about the health 
consequences of smoking can form part of an effective tobacco control program. Health publicity 
program designed for adults, however, has less conclusive beneficial effects on preventing young 
people to smoke. The Royal College of Physicians on the other hand argued in its 1992 report that 
interventions oriented to children were unlikely to be effective
 while the prevalence of adult smoking 
remains high, and so there
 is a need to help more adult smokers to quit [42]. Other benefits
 are likely to 
arise from a concentration on reducing smoking
 among adults with children. Reduced smoking by 
parents is likely
 to directly improve the health of non-smoking children and may
 reduce the extra 
healthcare
 costs among these children [43].  
Interventions to prevent tobacco use initiation and encourage cessation among young people need 
to reshape the environment so that it supports tobacco-free norms. As early adolescence (age 11–15 
years) is the period when young people are most likely to try smoking for the first time, intervening 
during adolescence is critical [24]. Since the late 1980s, most governments’ strategies to prevent the 
onset of cigarette smoking were often based on the premise that adolescents who engaged in smoking 
behavior had failed to comprehend the health hazards of smoking. The assumption was that these 
young people had a deficit of information that could be addressed by presenting them with health 
messages in a manner that caught their attention and provided them with sufficient justification not to 
smoke. Improvements in knowledge levels, or cognitive factors, would thus lead directly to changes in 
behavior. Unfortunately, many of the existing health education messages, delivered in the conventional 
fashion, appear to be overpowered by the glamour and image of smoking, vividly portrayed by the 
powerful tobacco companies [44]. One of the possible reasons is that young people are in their prime 
time of health and do not realise the full impact of the damaging effects of smoking as many of its 
related diseases tend to take sometime to develop. If young people are asked to make a “Choice” based 
on all the medical facts and data, they may take a risk to smoke as they might underestimate the Int. J. Environ. Res. Public Health 2009, 6          
 
 
76
potential risks of cigarettes. The dilemma therefore develops: should the health authorities ask the 
children to make a choice simply by giving them all the medical facts and passively trusting them to 
make a healthy choice, or alternatively impose them upon a smoke-free lifestyle with the danger of 
indirectly inducing them to experiment with smoking as a counter reaction to suppression. 
Health publicity as a standalone approach in itself is therefore not good enough. Community 
programs and school-based policies and interventions should be part of a comprehensive effort, 
implemented in coordination across the community and school environments and in conjunction with 
increasing the unit price of tobacco products, sustaining anti-tobacco media campaigns, making 
environments smoke-free, and engaging in other efforts to create tobacco-free social norms [45].  
On the other hand, tobacco companies are also taking the “Choice” battle by sponsoring various 
forms of “Choice” programs: disguised as tobacco prevention program under the name of social 
responsibility. These modified “Choice” programs use provocative messages for health advice in the 
context that the children is not old enough to make their own choice so they are “advised” not to 
smoke as they are too young. These types of modified choice programs make use of the rebellious 
nature of young people and arouse their desire to smoke, to be free to do something that challenges the 
authorities [46, 47]. It is probably one of these factors that renders health publicity programs for 
teenagers less conclusive due to the mixing up of tobacco prevention programs with “disguised” 
tobacco advocating programs. 
2.4. Tobacco Taxation 
When the price of cigarettes goes up, demand drops substantially. Increasing cigarette excise taxes 
is one way to cause the price of cigarettes to go up. Most researches suggest that cigarette companies 
pass the full amount of the tax increases through to consumers in the form of higher prices [48]. There 
have been many studies measuring the relationship between prices and the consumption of cigarettes, 
and most have similar results [45, 48-50]. In the short run, most studies find that a 25 percent increase 
in the price of cigarettes due to a tax increase will reduce consumption of cigarettes by just over 11 
percent [49]. There are also numerous studies all over the world clearly demonstrating that increases of 
tobacco tax would decrease the number of teenage smoking; younger smokers are more likely than 
older smokers to quit smoking in response to a price increase [50]. It would probably reduce the 
attractiveness of smoking among young people, as they have to depend on the financial support of 
their parents, and this will restrict their choice of expenditure items. In fact, the evidence was so 
overwhelming that the WHO claimed that “Increasing the price of tobacco through higher taxes is the 
single most effective way to decrease consumption and encourage tobacco users to quit [51]”.  
Tobacco price elasticity is estimated by the World Bank to be around –0.4 for developed countries, 
which means that a 10% rise in price leads to a 4% decline in consumption, but the reduction effects 
on consumption tended to be higher in developing than developed countries, and also higher among 
lower-income smokers, and younger smokers [52]. The increase in retail price of cigarettes will 
decrease their purchasing power to buy cigarettes, hence their daily consumption. Eventually, it will 
benefit their health and prevent the tobacco-related diseases. In general, price increases are found to be 
the most cost-effective antismoking intervention. In fact,  tobacco company’s internal documents Int. J. Environ. Res. Public Health 2009, 6          
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provide clear evidence on
 the impact of cigarette prices on cigarette smoking, describing
 how tax and 
other price increases lead to significant
 reductions in smoking, particularly among young persons [53]. 
2.5. Ban on Tobacco Promotion 
Cigarette manufacturers
 are in business to make a profit which depends on
 their ability to recruit 
new smokers. There is therefore a strong incentive for a tobacco company to compete
 for market share 
among beginning smokers, since the long-term prosperity of a given cigarette brand and company will 
depend
 on the percentage of new smokers that can be captured. A misguided debate has arisen about 
whether tobacco promotion “causes” young people to be nicotine-addicted because single-source 
causation is probably too simple an explanation for any social outcome. The more important issue is 
what effect tobacco promotion might have. The public health literature clearly demonstrates that youth
 
are exposed to a wide variety of industry marketing efforts,
 and that there is a consequent adverse 
effect upon adolescent
 smoking initiation rates [47, 52-54]. Current research suggests that pervasive 
tobacco promotion has two major effects: it creates the perception that more people smoke than they 
actually do, and it provides a conduit, between actual self-image and ideal self-image. In other words, 
smoking is made to look cool [37]. 
It has been suggested that the reactions of the tobacco industry to control strategies serve as a litmus 
test of potential effectiveness [55]. Banning promotion, setting prices policy, and establishing smoke-
free areas are the three strategies most vociferously opposed by the tobacco industry, a good indication 
of their importance [56]. These three strategies are therefore highlighted as the top three effective 
tobacco control approaches as listed in this paper. The remaining strategies described are not meant to 
be of less importance. Yet there are limitations, mainly streamed from resources implication and other 
political constraints that restrict direct application of these strategies in many countries. 
2.6. Product Litigation 
The U.S. tobacco giants are usually the targets for legal actions as they are the dominating exporters 
of tobacco products to the international market. Besides there are still many countries (over 40) with a 
tobacco monopoly, for example China, making it more difficult for citizens to sue, as it would in 
reality mean suing their own governments. Historically, tobacco litigation began with a personal injury 
lawsuit in the USA in 1954. For over 40 years, the tobacco industry boasted it had never lost a single 
case, but this was changed. One case in Minnesota that began in 1994 ruled that millions of pages of 
internal tobacco industry documents be put into the public domain [57]. These showed that the 
industry has concealed information on the true harmfulness of smoking and misled governments, the 
media and their customers. The disclosed documents also facilitate further lawsuits as internal 
documents from the tobacco companies turned out to be important evidence. 
When a Los Angeles jury assessed $28 billion in punitive
 damages against Philip Morris in Bullock 
versus Philip Morris Companies the tobacco control community cheered [58]. The jury had calculated
 
that only one in 28,000 Californians who have suffered from
 tobacco caused disease ever sues, so to 
make Philip Morris confront
 the real cost of its misbehavior, they multiplied a typical
 $1 million 
compensatory damage award (for medical bills, lost
 wages, and pain and suffering) by 28,000. In 
theory, further success of similar cases would bring down the tobacco giants financially.  Int. J. Environ. Res. Public Health 2009, 6          
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However not many plaintiffs, even in the form of a class action, can put up the energy and resources 
to battle with the tobacco companies on the endless litigation process – the progress of tobacco 
litigation can take years with no guarantee of successful endings. It is quite certain that tobacco 
companies will exhaust any appeal procedures to revert any decision that holds the tobacco companies 
responsible for the damages that their products caused to the victims. A major legal victory that pushes 
the tobacco companies into financial crisis remains to be seen. 
2.7. Quit Services 
The addictive nature of tobacco use can be broadly divided into two components - physical and 
psychological dependence [7]. Nevertheless, the role of how these two components interact with each 
other is not well defined. It is also not clearly understood why some smokers are easier than others to 
quit. On the other hand, there is overwhelming evidence that quitting provides enormous health 
benefits: Interventions that increase quitting can decrease premature mortality, morbidity, and tobacco-
related health care costs [59, 60]. Quitting by age 30 eliminates nearly all excess risk associated with 
smoking, and smokers who quit smoking before age 50 cut in half their risk of dying in the next 15 
years [61, 62]. Although there are many ex-smokers who quit successfully on their own, many more 
tobacco users want to quit but are unable to do so. More than 40% of smokers in United States try to 
quit each year. But without assistance, fewer than 10% succeed [63].  
To increase the success rate of tobacco use cessation, there are many quitting methods ranging from 
brief advice by medical providers to quit smoking, more intensive interventions (individual, group, or 
telephone counseling) that provide social support, and coaching on problem-solving skills, to 
pharmacotherapy such as nicotine replacement therapies, bupropion and varenicline. As a whole, 
nicotine replacement therapies and other pharmacological quitting aids can approximately double the 
chances that an individual will succeed in quitting compared with unaided attempts [60].  
Unfortunately the vast majority of countries do not help tobacco users who want to quit. Currently 
only 5% of the world’s population have access to treatment for tobacco dependence [1]. Due to the 
high relapse rate, tobacco dependence might be better viewed
 as a chronic disorder, requiring repeated 
episodes of treatment [64]. While some types of cessation treatment are less expensive than others, all 
require some kind of expenditure which can be difficult for some countries to fund. 
3. Conclusions  
It appears that countries which have not yet taken vigorous action against tobacco smoking have the 
highest percentage of smokers among their adult population. With rising cigarette consumption in 
these countries, one can expect substantial increases in lung cancer and their smoking-related diseases 
in the next 30-40 years. These countries would need to decide carefully on which tobacco control 
strategies they should channel their limited financial and time resources.  
On a macroscopic scale, it is obvious that increase of tobacco tax would be the top priority tobacco 
strategy to be adopted by the government. It is also possible to generate revenue through this taxation 
to fund other “non-price’ measures for tobacco control. A set of “non-price” measures has also been 
discussed, including comprehensive bans on advertising and promotion, information campaign, clean-
air restrictions, cessation treatment, and legal litigation.  Int. J. Environ. Res. Public Health 2009, 6          
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All of these effective tobacco policies have one feature in common: political actions with 
government support, funding, and protection are crucial. Without these, antismoking efforts in any part 
of the world are unlikely to be successful. For countries that have limited resources, they would need 
to concentrate on the most important policies among them. The answer as provided by Judith Mackay, 
around twenty years ago, is to place banning promotion, setting price policy and establishing smoke-
free areas as the top three priorities [56]. Her wisdom remains valid in the 21
st century. 
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